OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hydroxychloroquine lowers Alzheimer’s disease and related dementias risk and rescues molecular phenotypes related to Alzheimer’s disease
Vijay R. Varma, Rishi Desai, Sheeja Navakkode, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 3, pp. 1312-1326
Open Access | Times Cited: 21

Showing 21 citing articles:

Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression
Lucas Fornari Laurindo, Jefferson Aparecido Dias, Adriano Cressoni Araújo, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 38

Mitochondrial DNA leakage: underlying mechanisms and therapeutic implications in neurological disorders
Guangming Zhang, Huayuan Wei, Anliu Zhao, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 1

Population‐Based Validation Results From the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) Study
Rishi Desai, Vijay R. Varma, Mufaddal Mahesri, et al.
Clinical Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 1

Longitudinal progression of blood biomarkers reveals a key role of astrocyte reactivity in preclinical Alzheimer’s disease
VR Varma, Y An, PR Kac, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6

Clathrin mediated endocytosis in Alzheimer’s disease: cell type specific involvement in amyloid beta pathology
Sierra Jaye, Ursula S Sandau, Julie A. Saugstad
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 5

Cognitive impairment in individuals with rheumatic diseases: the role of systemic inflammation, immunomodulatory medications, and comorbidities
Elena Myasoedova, Sebastian E. Sattui, Jihae Lee, et al.
The Lancet Rheumatology (2024) Vol. 6, Iss. 12, pp. e871-e880
Closed Access | Times Cited: 5

A framework for translating tauopathy therapeutics: Drug discovery to clinical trials
Howard Feldman, Jeffrey L. Cummings, Adam L. Boxer, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 11, pp. 8129-8152
Open Access | Times Cited: 4

Molecular Mechanisms Underlying Neuroinflammation Intervention with Medicinal Plants: A Critical and Narrative Review of the Current Literature
Sandra Maria Barbalho, Beatriz Leme Boaro, Jéssica da Silva Camarinha Oliveira, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 133-133
Open Access

Evaluation of bumetanide as a potential therapeutic agent for Alzheimer’s disease
Ben Boyarko, Sonia Podvin, Barry Greenberg, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12

Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond
Jenny Garmendia, Claudia Valentina De Sanctis, Viswanath Das, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 6, pp. 1080-1109
Open Access | Times Cited: 6

Omaveloxolone ameliorates cognitive dysfunction in APP/PS1 mice by stabilizing the STAT3 pathway
Xiaolin Cui, Shuai Zong, Wenao Song, et al.
Life Sciences (2023) Vol. 335, pp. 122261-122261
Open Access | Times Cited: 5

A Peptide‐Drug Conjugate‐Based Nanoplatform for Immunometabolic Activation and In Situ Nerve Regeneration in Advanced‐Stage Alzheimer's Disease
Peixin Liu, Tongyu Zhang, Yuxing Wu, et al.
Advanced Materials (2024) Vol. 36, Iss. 46
Closed Access | Times Cited: 1

Triptolide activates the Nrf2 signaling pathway and inhibits the NF-κB signaling pathway to improve Alzheimer disease
Zuoting He, Benson O. A. Botchway, Yong Zhang, et al.
Metabolic Brain Disease (2023) Vol. 39, Iss. 1, pp. 173-182
Closed Access | Times Cited: 3

Exploring Shared Biomarkers of Myocardial Infarction and Alzheimer’s Disease via Single-Cell/Nucleus Sequencing and Bioinformatics Analysis
Weiqi Xue, Weifeng He, Mengyuan Yan, et al.
Journal of Alzheimer s Disease (2023) Vol. 96, Iss. 2, pp. 705-723
Open Access | Times Cited: 3

LAX1 as a Core Biomarker in Alzheimer's Disease and Periodontitis via the STAT signaling pathway
Han Guo, Tianyuan Guo, Xue Wang, et al.
Research Square (Research Square) (2024)
Open Access

Drug Repurposing for Effective Alzheimer’s Disease Medicines: Existing Methods and Novel Pharmacoepidemiological Approaches
Jackson A. Roberts, Vijay R. Varma, Attila Jones, et al.
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S299-S315
Closed Access

Targeted inference to identify drug repositioning candidates in the Danish health registries
Alexander W. Jung, Ioannis Louloudis, Søren Brunak, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Inhibition of Pyroptosis by Hydroxychloroquine as a Neuroprotective Strategy in Ischemic Stroke
Wenshuo Peng, Kaiming Guo, Jian Hu, et al.
eNeuro (2024) Vol. 12, Iss. 1, pp. ENEURO.0254-24.2024
Open Access

Page 1

Scroll to top